Gene · 6334
Papers2,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TEQUILA-seq: a versatile and low-cost method for targeted long-read RNA sequencing. | Nat Commun | 2023 | 37553321 | PubTator, text mining | PubMed |
| Cold and warmth intensify pain-linked sodium channel gating effects and persistent currents. | J Gen Physiol | 2023 | 37531097 | PubTator, text mining | PubMed |
| Based on network pharmacology and molecular docking to predict the mechanism of TMDZ capsule in the treatment of IS. | Medicine (Baltimore) | 2023 | 37505183 | PubTator, text mining | PubMed |
| Trends and hotspots in gene research of epilepsy in children: A review and bibliometric analysis from 2010 to 2022. | Medicine (Baltimore) | 2023 | 37505157 | PubTator, text mining | PubMed |
| A novel SCN8A variant of unknown significance in pediatric epilepsy: a case report. | J Int Med Res | 2023 | 37498161 | PubTator, text mining | PubMed |
| Creating rare epilepsy cohorts using keyword search in electronic health records. | Epilepsia | 2023 | 37498137 | PubTator, text mining | PubMed |
| Multidisciplinary molecular consultation increases the diagnosis of pediatric epileptic encephalopathy and neurodevelopmental disorders. | Mol Genet Genomic Med | 2023 | 37489029 | PubTator, text mining | PubMed |
| The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy. | Front Neurol | 2023 | 37483446 | PubTator, text mining | PubMed |
| Use of Sodium Channel Blockers in the Thr226Met Pathologic Variant of SCN1A: A Case Report. | Neuropediatrics | 2023 | 37467773 | PubTator, text mining | PubMed |
| MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control. | Proc Natl Acad Sci U S A | 2023 | 37463203 | PubTator, text mining | PubMed |
| Voltage-gated sodium channels: from roles and mechanisms in the metastatic cell behavior to clinical potential as therapeutic targets. | Front Pharmacol | 2023 | 37456756 | PubTator, text mining | PubMed |
| Physical activity and sleep relate to antibody maintenance following naturalistic infection and/or vaccination in older adults. | Brain Behav Immun Health | 2023 | 37456624 | PubTator, text mining | PubMed |
| The Role of Ion Channels in Functional Gastrointestinal Disorders (FGID): Evidence of Channelopathies and Potential Avenues for Future Research and Therapeutic Targets. | Int J Mol Sci | 2023 | 37446251 | PubTator, text mining | PubMed |
| Ataxia and Diplopia: A New SCN8A-Related Phenotype. | Neurol Genet | 2023 | 37440794 | PubTator, text mining | PubMed |
| Models of KPTN-related disorder implicate mTOR signalling in cognitive and overgrowth phenotypes. | Brain | 2023 | 37437211 | PubTator, text mining | PubMed |
| Mature and Myelinating Oligodendrocytes Are Specifically Vulnerable to Mild Fluid Percussion Injury in Mice. | Neurotrauma Rep | 2023 | 37435356 | PubTator, text mining | PubMed |
| Withdrawn: SCN1A Pathogenic Variants in a Turkish Cohort with GEFS+ Spectrum and Dravet Syndrome. | Epileptic Disord | 2023 | 37430418 | PubTator, text mining | PubMed |
| Tetra-Face-Capped Octahedra in a Tetrahedra Network - Structure Determination and Scanning Transmission Electron Microscopy of SrAl5 P4 N10 O2 F3. | Chemistry | 2023 | 37410334 | PubTator, text mining | PubMed |
| Ion Channels as Potential Tools for the Diagnosis, Prognosis, and Treatment of HPV-Associated Cancers. | Cells | 2023 | 37408210 | PubTator, text mining | PubMed |
| Novel potentially pathogenic variants detected in genes causing intellectual disability and epilepsy in Polish families. | Neurogenetics | 2023 | 37405542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6334/papers?page=14